RANDY CZTERNASTEK: Open Payments
NPI 1922239086 · NEW HARTFORD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,606 in 109 payments from 22 companies in 2025. Trend: 2023 $2,725 · 2024 $2,174 · 2025 $1,606
Food & beverage: $1,606
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $362 |
| PFIZER INC. | 20 | $240 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $203 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $139 |
| TOLMAR, INC. | 5 | $94 |
| Axsome Therapeutics, Inc. | 4 | $87 |
| Novo Nordisk Inc | 3 | $67 |
| Esperion Therapeutics, Inc. | 3 | $56 |
| UCB, Inc. | 2 | $55 |
| Lundbeck LLC | 2 | $40 |
Products named: NURTEC ODT, QULIPTA, CAPLYTA, XIFAXAN, JATENZO, Auvelity, UBRELVY, VRAYLAR.
Industry payments across NY — which companies pay providers there.
